Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN

• Kaja S. Borge ,

  * E-mail: kaja.sverdrup.borge@nmbu.no

  Affiliation Section of Genetics, Department of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences (NMBU),Oslo, Norway

  ⨯
• Silje Nord,

  Affiliation Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway

  ⨯
• Peter Van Loo,

  Affiliations Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom, Human Genome Laboratory, Department of Human Genetics, VIB and University of Leuven, Leuven, Belgium

  ⨯
• Ole C. Lingjærde,

  Affiliations Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway, Biomedical Informatics, Department of Informatics, University of Oslo, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯
• Gjermund Gunnes,

  Affiliation Section of Anatomy and Pathology, Department of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences (NMBU), Oslo, Norway

  ⨯
• Grethe I. G. Alnæs,

  Affiliation Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway

  ⨯
• Hiroko K. Solvang,

  Affiliation Marine Mammals Research Group, Institute of Marine Research, Bergen, Norway

  ⨯
• Torben Lüders,

  Affiliations Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Clinical Molecular Biology and Laboratory Sciences (EpiGen), Akershus University Hospital, Lørenskog, Norway

  ⨯
• Vessela N. Kristensen,

  Affiliations Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway, The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Clinical Molecular Biology, Division of Medicine, Akershus University Hospital, Ahus, Norway

  ⨯
• Anne-Lise Børresen-Dale,

  Affiliations Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Radiumhospitalet, Oslo, Norway, The K. G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Frode Lingaas

  Affiliation Section of Genetics, Department of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences (NMBU),Oslo, Norway

  ⨯